MSK researcher: AI-designed proteins to push tumor-control limits in preclinical models
anshulkundaje · x · 2026-09-10
Caleb Lareau of Memorial Sloan Kettering Cancer Center says his team will keep pushing what AI-designed proteins can do to control tumors in preclinical models over the next few years, aiming to meet patient needs soon.
Related event: MSK's AI-Designed Anti-Cancer Proteins Fully Clear Tumors in Mice(3 posts)→
More from Research
- Salesforce releases EvoHarnessBench to test agents against evolving tool harnesses — Salesforce · 2026-09-10
- Cornell uses AlphaFold to uncover new class of cellular 'off switch' linked to cancer — Dr_Singularity · 2026-09-10
- AI-built app visualizes Rentosertib anti-aging drug mechanism in ~40 minutes — DeryaTR_ · 2026-09-10
- AlphaFold helps Cornell researchers discover hidden cellular 'off switch' linked to cancer — Dr_Singularity · 2026-09-10
- Anthropic, FutureBio and HackIterate team up for cross-domain hard science push in October — Thom_Wolf · 2026-09-10
- Tsinghua + Qwen paper: rebuilding agent workspaces beats imitating trajectories, lifts Terminal-Bench to 58.1% — rohanpaul_ai · 2026-09-10